Tumor-driven factors like TNF-α, GM-CSF, HMGB1, IL-6, CCL20, and hypoxia boost PD-L1 levels in neutrophils, dampening immune responses, particularly T cells [71–74, 107–109]. The gene discussed is CSF2; the disease is neoplasm.